Fierce Cloud Services for Biopharma R&D

Cloud computing--a data-crunching force multiplier that allows companies to draw on resources across the Internet, either on the fly or as a dedicated service--is potentially disruptive to companies because it changes the dynamic of who owns the capital assets, turning traditional IT infrastructure models on their heads.

Do your homework before selecting a cloud service provider. That's the message from those who know.

"Be cautious, but be open-minded," says Rick Franckowiak, director for systems engineering at the Pharmaceutical Research & Development IT organization of Johnson & Johnson. Likewise: "Be careful," says Brian Boruff, vice president for cloud computing at systems integration consultancy Computer Sciences Corp., a cloud service provider.

Boruff and Franckowiak explained to FierceBiotech IT the need for such caution, as well as characteristics to look for in cloud service offerings: security, agility, cost elements and biopharma suitability. A summary of our interviews with these experts is available here.

The following pages contain descriptions of a representative sampling of cloud service providers and their offerings. Many such services are available now and the list of providers and offerings is growing rapidly. For this report, we've included a mix of generalists and those with pharma-specific offerings. Descriptions are culled from company information.

Representative cloud service providers, in alphabetical order:

  • Amazon

  • CSC

  • EMC

  • Google

  • IBM

  • Microsoft

  • Oracle
Fierce Cloud Services for Biopharma R&D

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.